Federal billing protections have saved patients nearly $1 billion annually, though corporate coverage cuts for obesity medications signal new challenges for healthcare access.
A new analysis released by HaloMD indicates that federal efforts to curb predatory medical billing are yielding significant results. The No Surprises Act, designed to protect patients from unexpected bills when receiving emergency care from out-of-network providers, has reduced emergency medical spending by as much as 52%. This shift represents an estimated annual savings of nearly $1 billion, providing a victory for fiscal transparency in a system often criticized for opaque pricing. By removing the patient from payment disputes between insurers and providers, the law has begun to restore predictability to the financial side of the doctor-patient relationship.
While federal policy has successfully reined in some emergency costs, the private sector is pushing back against rising pharmaceutical spending. The Obesity Action Coalition recently called on PepsiCo to reverse its decision to terminate coverage for GLP-1 medications for obesity. Starting in October, certain employees will lose access to these high-demand drugs, highlighting a growing tension between individual health needs and corporate bottom lines. As employers grapple with the high cost of innovative treatments, the burden of choice often falls on the patient, threatening the continuity of care for those managing chronic conditions. This move may signal a broader trend of corporations tightening formularies to protect margins from the high price tags of modern biologics.
Simultaneously, the regulatory landscape for specialized treatments continues to evolve. The FDA recently cleared Kali Therapeutics’ Investigational New Drug application for KT501, a first-in-class tri-specific T-cell engager for autoimmune diseases. This milestone reflects a steady march toward personalized medicine. Additionally, the medical device sector continues to innovate with the launch of the Liv pre-lubricated intermittent catheter for women by HR HealthCare, demonstrating that market competition remains a primary driver for improving patient quality of life through specialized equipment.
Infrastructure and access remain critical concerns. In Michigan, Select Medical and Corewell Health have formed a joint venture to address specialized care gaps by building an 84-bed inpatient rehabilitation hospital in Sterling Heights. This expansion serves as a reminder that localized, high-quality care facilities are essential for post-acute recovery. Furthermore, the Department of Defense has awarded a five-year contract to Knowesis to support awards management for Congressionally Directed Medical Research Programs, ensuring that federal research dollars continue to flow toward critical medical advancements.
These domestic advancements stand in stark contrast to deteriorating conditions in international conflict zones. The Gaza Health Ministry reported this week that 70% of hospital generators are out of service due to fuel and spare-parts shortages. This crisis has left critical departments on the verge of total shutdown, with the WHO warning that diesel deliveries will cease on September 19 due to a funding shortfall. The resulting impact on ICUs and dialysis services underscores the fragility of healthcare delivery when separated from stable funding and secure supply chains.
Whether through the No Surprises Act or the struggle over drug formulary inclusions, the central theme remains the same: the patient is caught between the promise of medical innovation and the reality of its price tag. Maintaining the sacred doctor-patient relationship requires a commitment to market competition that prioritizes transparency and individual liberty over administrative convenience. As policy experts and clinicians convene at Psych Congress 2026 to examine federal policy on emerging medicines, the focus must remain on ensuring that fiscal responsibility does not come at the cost of patient outcomes.
Susan Carter serves as a Senior Correspondent for Just Right News, where she leads the network’s comprehensive coverage of Health, Medicine, and Public Policy. With a career dedicated to dissecting the complexities of the American healthcare system, Susan brings a principled perspective to the most pressing debates of the day. Her reporting is characterized by a commitment to individual liberty, fiscal responsibility, and a healthy skepticism of government overreach, making her a vital voice for audiences seeking clarity in an increasingly regulated landscape.
Raised in Minneapolis, Minnesota, Susan’s professional outlook is deeply informed by the values of the American heartland. Growing up in the Twin Cities, she witnessed firsthand the importance of community-driven solutions and the resilience of the individual. This Midwestern foundation instilled in her a firm belief that the best answers to public policy challenges often come from local innovation and personal responsibility rather than top-down federal mandates. Her background allows her to translate complex legislative jargon into stories that resonate with families who value common sense and local autonomy.
Now based in Baltimore, Maryland, Susan operates from a unique vantage point at the intersection of medical innovation and urban policy. Living and working in a city renowned for its world-class medical institutions and significant public health challenges, she has a front-row seat to the realities of the modern healthcare landscape. Her proximity to these hubs of research and policy allows her to scrutinize how government intervention affects the quality of care and the freedom of medical professionals. In Baltimore, she sees the tangible results of policy decisions, using the city as a lens through which to examine the broader national health debate and the impact of federal spending on local communities.
As the lead for the acclaimed feature series “The Cost of Care,” Susan dives deep into the economic realities facing patients and providers alike. Her work focuses on the necessity of price transparency, the benefits of market competition, and the preservation of the sacred doctor-patient relationship. She is a staunch advocate for the idea that a well-informed public is the best defense against bureaucratic inefficiency. Through this series, she has exposed the hidden drivers of rising medical expenses, always seeking to empower the individual consumer over the massive institution.
Susan’s reporting on public policy is characterized by a commitment to rigorous inquiry and a focus on constitutional limits. Whether she is analyzing new pharmaceutical regulations, investigating the impact of federal health mandates, or exploring the future of medical technology, her goal remains the same: to provide Just Right News audiences with the facts they need to navigate a complex world. By blending her Midwestern sensibilities with the insights gained from her base in Maryland, Susan Carter has become a trusted authority for those who believe that personal freedom and public health are inextricably linked. Her work continues to challenge the status quo, advocating for a system that respects the taxpayer and prioritizes the patient.